Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 20 Anorexia 11 Cachexia 9 Neoplasms 8 Breast Neoplasms 8 Endometrial Hyperplasia 7 Weight Loss 3 Recurrence 2 Overweight 2 Obesity 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Body Weight Changes 2 Body Weight 2 Vomiting 1 Turcot syndrome 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Prosthesis Failure 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Nutrition Disorders 1 Neoplasms, Second Primary 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Menorrhagia 1

Interventions

Mitotane 10 Cisplatin 9 pembrolizumab 7 Doxorubicin 6 Etoposide 5 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 relacorilant 3 cabozantinib 3 Cytoreduction Surgical Procedures 3 sodium thiosulfate 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Trastuzumab 2 Suramin 2 Radiotherapy 2 Ipilimumab 2 Dichlorodiphenyldichloroethane 2 Cyclophosphamide 2 tipifarnib 1 pegfilgrastim 1 milademetan 1 lenvatinib 1 iodophenyl metomidate 1 gossypol acetic acid 1 fludarabine phosphate 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × Megestrol Acetate × Clear all

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡